Overview

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Status:
Enrolling by invitation
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
October 6 University
Treatments:
Cerebrolysin
Prednisolone